Inactive Instrument
Avanir Pharmaceuticals Inc Stock
Stocks
US05348P4019
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-12-02 | Otsuka : Japan's Otsuka to buy Avanir for $3.5 billion ahead of patent cliff | RE |
| 14-11-17 | NASDAQ OMX : names 14 stocks to test lower fee and rebate programme | RE |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.76% | +3.62% | +49.92% | +101.12% | 69.69B | |
| +2.29% | +1.43% | +38.39% | +77.80% | 61.24B | |
| +0.53% | -3.07% | -14.79% | +364.67% | 26.77B | |
| +0.32% | +2.58% | +29.26% | +14.12% | 26.12B | |
| +3.34% | +2.95% | +1.12% | -8.98% | 24.07B | |
| +1.49% | +7.73% | +26.85% | -13.79% | 20.39B | |
| -0.83% | -11.15% | +169.70% | +295.44% | 15.72B | |
| +2.06% | +0.92% | +43.32% | +171.48% | 14.07B | |
| +0.17% | -4.07% | -9.71% | +484.05% | 14.03B | |
| Average | +1.22% | -1.18% | +37.12% | +165.10% | 30.23B | |
| Weighted average by Cap. | +1.51% | +0.20% | +36.43% | +129.71% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
